Search Orphan Drug Designations and Approvals
-
Generic Name: | Bezuclastinib |
---|---|
Date Designated: | 03/17/2023 |
Orphan Designation: | Treatment of Mastocytosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Cogent Biosciences, Inc. 275 Wyman Street 3rd Floor Waltham, Massachusetts 02451 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-